Research has shown that more than a third of anti-malarial drugs sold in Africa have failed quality tests. The study of drugs bought in Ghana, Kenya, Nigeria, Rwanda, Tanzania and Uganda reveals that 35 percent contained too little active ingredient or failed to dissolve, rendering them ineffective.

Another third of the treatments also belonged to a class of drugs that the World Health Organization (WHO) wants to be banned because they can cause the malaria parasite to develop resistance.

The Times of London reports that, “the findings suggest that hundreds of thousands of lives are being put at risk and indicates that drug counterfeiting is to blame. Researchers fear this is spreading to Africa from South-East Asia, where up to 50 percent of anti-malarial drugs are faked. Malaria kills up to 2.7 million people each year chiefly in Africa, and counterfeit and substandard drugs may account for at least 200,000 deaths.

To read the entire article from the Times, link here:

This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Comments (1)

Comment	smaller | bigger
Name
Write the displayed characters
Subscribe via email (Registered users only) I have read and agree to the Terms of Usage.
	Add Comment